Abstract
Tricuspid regurgitation (TR) resulting from valve abnormalities necessitates precise diagnostic tools and interventions. We employed a simulated heart movement device to examine the performance of heart valve functions and analyzed internal pressure changes to provide a quantitative guide for TR treatment. We developed a simulator capable of replicating the flow profile, mimicking natural heart movements, with sensors installed for measuring internal pressure changes. We conducted an ex vivo experiment on a porcine heart to assess tricuspid valve functionality. An endoscope was installed, with a sensor and endoscopic images to detect abnormalities. TR became evident when the heart rate spectrum exceeded an average of 85.2 bpm (standard deviation, 1.3 bpm) and showed an amplitude higher than an average of 12.3 mmHg (standard deviation, 3.2 mmHg). This critical threshold consistently indicated TR onset. The application of the Pivot-TR attenuated this specific spectral area. We confirmed TR disappearance by reducing the intensity of the Tricuspid Regurgitation Generator or employing the Pivot-TR. The Pivot-TR’s ability to attenuate specific spectral areas associated with TR onset and its effectiveness in restoring normal heart functionality has implications for managing and treating TR, particularly that resulting from age-related structural changes in the heart.
Abstract as published in Applied Sciences, 2024;14(8):3307, reproduced without changes (source: Crossref DOI 10.3390/app14083307). Read the full article on the publisher's site.
Related publications
CCI 2026 · Clinical
Safety and Efficacy of Pivot-Bridge for Severe Functional Tricuspid Regurgitation: The First-in-Human Experiences
View detailsEuroIntervention 2026 · Clinical
A novel spacer for transcatheter treatment of tricuspid regurgitation
View detailsKCJ 2025 · Clinical
